Skip to content

Clinical trials

Invasive Fungal Infections trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Invasive Fungal Infections Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20103
20171
20182
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center3
Astellas Pharma Inc2
Astellas Pharma Singapore Pte. Ltd.1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Dongkook Pharmaceutical Co., Ltd.1
F2G Biotech GmbH1
F2G Ltd1
Merck Sharp & Dohme LLC1
Samsung Medical Center1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Invasive Fungal Infections13
Aspergillosis3
Candidemia2
Candidiasis, Invasive2
Candidiasis1
Coccidioidomycosis1
Febrile Neutropenia1
Fungemia1
Graft vs Host Disease1
Hematologic Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.